MGC Pharmaceuticals Ltd. | Income Statement
Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
-
-
2.20
120.20
296.80
Cost of Goods Sold (COGS) incl. D&A
94.50
-
210.10
1,009.00
1,260.20
Gross Income
94.50
-
207.90
888.80
963.30
SG&A Expense
307.90
812.40
2,253.10
5,853.30
5,494.30
EBIT
511.60
812.40
2,461.00
6,742.10
8,359.50
Unusual Expense
4,835.00
2,777.40
3,535.90
1,527.70
2,108.00
Non Operating Income/Expense
1.60
213.90
159.20
339.80
517.10
Interest Expense
-
-
120.00
19.70
99.40
Pretax Income
5,337.80
3,797.80
6,230.10
8,502.00
10,892.30
Income Tax
-
-
-
-
1,901.90
Consolidated Net Income
5,337.80
3,797.80
6,230.10
8,502.00
8,990.50
Net Income
5,337.80
3,797.80
6,157.10
8,144.40
8,247.40
Net Income After Extraordinaries
5,337.80
3,797.80
6,157.10
8,144.40
8,248.40
Net Income Available to Common
5,337.80
3,797.80
6,157.10
8,144.40
8,246.30
EPS (Basic)
0.03
0.01
0.01
0.01
0.01
Basic Shares Outstanding
159,962.80
282,809.50
603,562.80
966,344.10
1,125,542.70
EPS (Diluted)
0.03
0.01
0.01
0.01
0.01
Diluted Shares Outstanding
159,962.80
282,809.50
603,562.80
966,344.10
1,125,542.70
EBITDA
511.60
812.40
2,444.40
6,658.60
8,031.40
Other Operating Expense
109.10
-
-
-
1,901.90
Non-Operating Interest Income
7.10
5.90
46.00
127.30
191.60
Minority Interest Expense
-
-
72.90
357.70
743.10
About MGC Pharmaceuticals
View Profile
